Business Wire - Salmedix, Inc. Announces the Initiation of Two New Clinical Tri
Posted on Thursday, September 30 @ 07:00:00 CDT by admin
September 30, 2004 -- SAN DIEGO -- A New Phase II Study of SDX-101 for Chronic Lymphocytic Leukemia, and a Cooperative Group Study of SDX-102 for Brain Cancer Salmedix, ...
Click Here to read the entire article...
|
| |
|